CN117281993A - Painless facial integral shaping method based on facial neuromuscular block - Google Patents
Painless facial integral shaping method based on facial neuromuscular block Download PDFInfo
- Publication number
- CN117281993A CN117281993A CN202211014391.3A CN202211014391A CN117281993A CN 117281993 A CN117281993 A CN 117281993A CN 202211014391 A CN202211014391 A CN 202211014391A CN 117281993 A CN117281993 A CN 117281993A
- Authority
- CN
- China
- Prior art keywords
- point
- facial
- injection
- painless
- shaping
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001815 facial effect Effects 0.000 title claims abstract description 64
- 238000007493 shaping process Methods 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 30
- 206010029315 Neuromuscular blockade Diseases 0.000 title claims abstract description 14
- 238000002347 injection Methods 0.000 claims abstract description 68
- 239000007924 injection Substances 0.000 claims abstract description 68
- 238000003780 insertion Methods 0.000 claims abstract description 18
- 230000037431 insertion Effects 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 230000000903 blocking effect Effects 0.000 claims abstract description 11
- 230000008569 process Effects 0.000 claims abstract description 11
- 238000007665 sagging Methods 0.000 claims abstract description 11
- 210000003205 muscle Anatomy 0.000 claims abstract description 9
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960004194 lidocaine Drugs 0.000 claims abstract description 7
- 230000002232 neuromuscular Effects 0.000 claims abstract description 5
- 229940090044 injection Drugs 0.000 claims description 66
- 210000003491 skin Anatomy 0.000 claims description 40
- 210000005036 nerve Anatomy 0.000 claims description 35
- 210000004709 eyebrow Anatomy 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 14
- 230000002123 temporal effect Effects 0.000 claims description 12
- 210000001519 tissue Anatomy 0.000 claims description 12
- 210000001747 pupil Anatomy 0.000 claims description 11
- 230000035807 sensation Effects 0.000 claims description 11
- 210000000988 bone and bone Anatomy 0.000 claims description 8
- 210000000216 zygoma Anatomy 0.000 claims description 8
- 210000004373 mandible Anatomy 0.000 claims description 7
- 206010002091 Anaesthesia Diseases 0.000 claims description 6
- 230000037005 anaesthesia Effects 0.000 claims description 6
- 210000003195 fascia Anatomy 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 208000017520 skin disease Diseases 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000007920 subcutaneous administration Methods 0.000 claims description 6
- 210000003901 trigeminal nerve Anatomy 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 210000004204 blood vessel Anatomy 0.000 claims description 5
- 210000000966 temporal muscle Anatomy 0.000 claims description 5
- 108010057266 Type A Botulinum Toxins Proteins 0.000 claims description 4
- 230000008595 infiltration Effects 0.000 claims description 4
- 238000001764 infiltration Methods 0.000 claims description 4
- 238000004898 kneading Methods 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 241001313288 Labia Species 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 229960003260 chlorhexidine Drugs 0.000 claims description 3
- 230000001886 ciliary effect Effects 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 210000001061 forehead Anatomy 0.000 claims description 3
- 229940025300 lidocaine injection Drugs 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 3
- 208000035143 Bacterial infection Diseases 0.000 claims description 2
- 208000036142 Viral infection Diseases 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 238000009792 diffusion process Methods 0.000 claims description 2
- 210000002615 epidermis Anatomy 0.000 claims description 2
- 238000005286 illumination Methods 0.000 claims description 2
- 208000027866 inflammatory disease Diseases 0.000 claims description 2
- 230000009385 viral infection Effects 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims 1
- 230000006835 compression Effects 0.000 claims 1
- 238000007906 compression Methods 0.000 claims 1
- 230000000249 desinfective effect Effects 0.000 claims 1
- 230000023597 hemostasis Effects 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 9
- 230000032683 aging Effects 0.000 abstract description 5
- 108030001720 Bontoxilysin Proteins 0.000 abstract description 4
- 229940053031 botulinum toxin Drugs 0.000 abstract description 4
- 210000001508 eye Anatomy 0.000 description 10
- 238000002676 facial rejuvenation Methods 0.000 description 10
- 230000037303 wrinkles Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 102000029816 Collagenase Human genes 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 229960002424 collagenase Drugs 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000001097 facial muscle Anatomy 0.000 description 3
- 210000000256 facial nerve Anatomy 0.000 description 3
- 208000004929 Facial Paralysis Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 2
- 208000024248 Vascular System injury Diseases 0.000 description 2
- 208000012339 Vascular injury Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 206010049244 Ankyloglossia congenital Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940094657 botulinum toxin type a Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001808 exosome Anatomy 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M19/00—Local anaesthesia; Hypothermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/42—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for desensitising skin, for protruding skin to facilitate piercing, or for locating point where body is to be pierced
- A61M5/422—Desensitising skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/42—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for desensitising skin, for protruding skin to facilitate piercing, or for locating point where body is to be pierced
- A61M5/427—Locating point where body is to be pierced, e.g. vein location means using ultrasonic waves, injection site templates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The invention provides a painless facial overall shaping method based on facial neuromuscular block, which comprises two major parts of painless shaping and facial shaping. According to the point A to G, the injection A is matched with the lag, the whole face can be painless, then the injection B of the botulinum toxin and the lidocaine is added, and the muscle retardation is carried out by the mixed liquid of the lidocaine and the botulinum toxin, so that the painless face shaping effect is achieved. The neuromuscular blocking can reduce pain of a patient, is painless in the whole process, solves the problem that the shaping process is greatly puzzled due to pain of the user, improves comfort of the user, and is better in experience. According to the needle insertion point, the needle insertion direction and the needle insertion depth which are specially designed, the operation flow is simplified, the outer sagging of the upper face and the middle face can be effectively corrected only by two steps of operation, the aging of the face caused by the outer sagging of the upper face and the middle face is reduced, the face is more younger, and the machine is promoted.
Description
Technical Field
The invention relates to the field of neuromuscular blockade, in particular to a painless facial integral shaping method based on facial neuromuscular blockade.
Background
The face is one of the most densely distributed regions of nerve endings in the human body, and is also the most expressive part, and is an important organ for people's emotion, thinking and external communication. Along with the continuous improvement of the living standard of people, the demands for facial rejuvenation are increased, various facial rejuvenation technologies and projects are increased, the skin is tender or deep wrinkle is removed, pain stimulation of the skin is involved, various facial rejuvenation projects can be completed comfortably, painlessly and loosely, and the important points and difficulties are faced when the projects are developed.
The traditional common skin painless measures comprise externally applying auxiliary materials (such as lidocaine patch, ointment, etc.) containing anesthetic on the face, wherein the external application time is longer than 30 minutes. The fine part of the anatomy (the part around the eye, nose bridge, nose root, nose tip, etc.) cannot be covered or is not covered completely, and the pain relieving effect is poor. Nerve blocking on the trigeminal nerve and the facial nerve branches can effectively form a facial painless area, is convenient for the implementation of facial rejuvenation technology, has extremely high requirements on operators, and can be implemented by a professional technical training party: (1) when the nerve is blocked, the puncture part has deviation, so that the blocking effect is poor, and the subsequent operation is influenced; (2) incorrect manipulation is easy to accidentally injure nerves and accompanying blood vessels, and causes complications such as nerve vascular injury, intracranial infection, facial paralysis, eyeball injury and the like.
The first point of facial rejuvenation operation is safety, and the second is natural and durable effect. The human face is one of the most complex regions of the human body, and new insights of different facial structures and complex correlations between them are continuously proposed in the research of facial shaping. The open or non-open treatment of cosmetic surgery is varied in order to slow down aging and restore youthful and beautiful facial appearance.
The existing facial beauty projects can cause severe pain and discomfort of users no matter anti-wrinkle whitening or anti-aging, intradermal injection of medicines (wrinkle removing agents, stem cells or exosomes and the like) or injection of fillers, because facial muscle tissues are less, particularly nose bridge and eyebrow core parts, skin bottoms are bones, injection molding is very painful, the molding process is greatly puzzled, users cannot tolerate the skin, experience extremely bad feeling, the users are easy to feel dysphoria, even pale complexion, acceleration of heartbeat, nausea and other nervous reactions are generated, and the molding process is frustrated, so that a method for reducing the pain of the users is lacking in the facial molding process.
Aging of the face, including loss of luster and elasticity of the skin, wrinkles, loss of collagen in tissues of each layer of the face, loss of support of tissue structures under the skin, sagging of the face, especially sagging of tissue structures (external corners of eyes and external corners of mouth) on the outer side of the upper face and middle face, forms senile facial phases such as bitter faces, french lines and the like. The whole shaping of face aims at removing facial wrinkles, locally improving sagging of the outer sides of the upper face and the middle face, correcting aging face appearance such as bitter face and stature lines and the like by the whole shaping of the face, and achieving the aim of face rejuvenation.
According to the above situation, we propose a facial painless facial shaping technical scheme based on neuromuscular block, simplifying operation flow and facilitating clinical implementation.
Disclosure of Invention
The invention aims to provide a painless facial integral shaping method based on facial nerve and muscle block, which can painless carry out facial integral shaping, and the muscle block can shape the facial muscle tissue of a specific part so as to achieve a facial shaping effect, and the nerve block can lead a patient to feel no pain.
In order to achieve the above purpose, the present invention proposes the following technical scheme: a painless facial overall shaping method based on facial neuromuscular blockade, comprising the following steps:
s1: marking A, B, C, D, E, F, G positioning points by using a marker pen before injection, wherein the point A corresponds to the branch of the trigeminal nerve, namely the supraorbital nerve, and the skin feel of the forehead is dominated; point B corresponds to the branch of the trigeminal nerve, the infraorbital nerve, innervating the skin sensations of the lateral nasal, cheek, upper lip and temporal; point C corresponds to the branches of the trigeminal nerve-the chin nerve, innervating the skin sensation of the labia, mandible and part of the temporal part; point D corresponds to the supratrochlear nerve, innervating the skin feel between the eyebrows; point E corresponds to the nasal ciliary nerves, corresponds to the skin feel of the nasal root, bridge of the nose, wings of the nose; F. point G, corresponding to the zygomatic temporal nerve, innervates the periocular lateral temporal skin sensation;
s2: preparing medicine injection A and B, and preparing the injection A: 5ml of 2% lidocaine is added with 5ml of water for injection or 0.9% saline to prepare 1% lidocaine injection; preparation of injection B: dissolving and diluting 2ml of physiological saline to obtain freeze-dried powder of botulinum toxin A, extracting 2ml of the dissolved and diluted solution, and mixing with 2ml of prepared injection A to prepare injection B for later use;
s3: sterilizing the face by using a sterilizing liquid, extracting 2ml of the injection A by using an injector, connecting a 22G needle head, inserting the needle at the positioning point, stopping inserting the needle after touching the bone face, withdrawing no blood, slowly injecting 0.5ml of the injection to form a local skin dome, withdrawing the needle immediately and lightly kneading an injection part, fading and diffusing the liquid medicine by using Li Piqiu, blocking each nerve branch near the injection point, and completing painless operation;
s4: taking injection B, injecting injection B1-2 ml in layers according to a lifting and shaping scheme, and finishing facial shaping, wherein the upper facial lifting shaping comprises upper facial lifting shaping and middle facial lifting shaping, wherein a needle inlet point is positioned at the position of an eyebrow tip obliquely outwards and upwards, a needle is in a fan shape along a subcutaneous/deep fascia gap, the needle inlet depth is 2-3 cm, the injection B2 ml reaches the anterior muscle bundle of temporal muscles, neuromuscular blocking lag is carried out, and the area where the external canthus is positioned, namely the lifting of the outer part of the upper face and the sagging of the outer side of the upper face can be effectively lifted;
the middle facial lifting and shaping is as follows, the needle insertion point is located at the highest point of the zygomatic arch, is obliquely located at 30 degrees above the outer side, is in a fan shape along the subcutaneous/deep fascia space (SMAS), the needle insertion depth is 4-5 cm, and injection liquid B2 ml is respectively injected along the upper, middle and lower edges of the zygomatic arch in each direction, so that the external angle of the mouth can be effectively lifted, the stature lines are lightened, and the sagging of the outer side of the middle facial is corrected.
After the steps, the lifting and shaping of the upper face and the middle face are completed.
Based on the painless treatment scheme, collagenase injection, facial wrinkle removal or photon skin tendering and other operations requiring painless treatment can also be performed.
Preferably, point a is located at the orbital rim above the pupil; point B, located at the orbital rim below the pupil; the point C is positioned outside the angle of the mouth and above the lower edge of the mandible and can be positioned on the same straight line with the point A and the point B; a point D, which is positioned at the inner side end of the eyebrow; e, locating at the nose root and inner canthus part of eye; point F, located at the outer canthus, orbital rim of the eye; and the G point is positioned at the outer side end of the eyebrow and the position of the eyebrow tip.
Preferably, each positioning point A, B, C, D, E, F, G is shallow, and can reach the bone surface by penetrating 3-4 mm of the skin, and the needle cannot be inserted too deeply in the operation process so as not to hurt the deep tissue structure. After puncturing in place, attention is paid to back suction, and the injection of the medicine into the blood vessel is avoided.
Preferably, the disinfectant in the step S3 is iodophor, chlorhexidine or 75% alcohol.
Preferably, in S3, the needle insertion depth and the needle insertion angle are determined according to the facial condition, and the needle insertion is performed with the layer-by-layer infiltration anesthesia, wherein the needle insertion is based on the human tissue anatomical structure, and the anesthesia needle enters each layer of human tissue anatomical structure layer through the epidermis to perform the layer-by-layer infiltration anesthesia.
Preferably, the skin is cleaned before injection, the skin is inspected, the site of the patient to be injected is carefully inspected by the illumination device, whether the site of the patient to be injected has skin diseases, active bacterial or viral infections, inflammatory diseases, etc., if the skin diseases are present, the injection should be stopped, if the skin diseases are not present, etc., the subsequent injection process is continued, and the line drawing site is carefully disinfected by iodophor before injection.
The beneficial effect, the technical scheme of this application possesses following technical effect:
1. the invention can painless carry out integral facial shaping, muscle block can shape the expression muscle of a specific part so as to achieve a facial shaping effect, nerve block can lead a patient not to feel pain, the whole process is painless, the problem that the shaping process is greatly plagued by pain of a user in the shaping process is solved, the experience of the user is good, the smooth proceeding of the shaping process is facilitated, the shaping process is enabled to be civilized, quiet and elegant, the operation time can be shortened, and the user obtains better comfort and satisfaction.
2. The invention carries out positioning marking by means of the body surface structures such as pupils, eyebrows, inner canthus and the like which are visible to naked eyes and are easy to identify, and the method is simple and convenient and is easy to operate. According to the neuroanatomical positioning, the neuroanatomical position is not emphasized any more, but the body surface marks are highlighted; is easier to learn and memorize. According to the lag of points A-G, the whole face can be painless. The oblique upward, backward and upward injection and shaping of the temporal muscle and the zygomatic arch are the core of the invention, mainly act on the SMAS and are the important points for facial shaping and lifting.
3. The invention relates to painless and facial shaping, wherein painless contents relate to injection, point selection positioning and preparation of liquid medicine A. Preparing a liquid medicine B: the addition of botulinum toxin in the secondary formulation of local anesthetics is one of the advantages of this patent, traditional A-type botulinum toxin is formulated with normal saline, because normal saline pH is acidic, the local injection is severely stimulated and painful, and the comfort during injection is seriously affected. After adding local anesthetic, the pain and uncomfortable feeling during injection and shaping are further relieved on the basis of nerve block.
It should be understood that all combinations of the foregoing concepts, as well as additional concepts described in more detail below, may be considered a part of the inventive subject matter of the present disclosure as long as such concepts are not mutually inconsistent.
The foregoing and other aspects, embodiments, and features of the present teachings will be more fully understood from the following description, taken together with the accompanying drawings. Other additional aspects of the invention, such as features and/or advantages of the exemplary embodiments, will be apparent from the description which follows, or may be learned by practice of the embodiments according to the teachings of the invention.
Drawings
Embodiments of various aspects of the invention will now be described, by way of example, with reference to the accompanying drawings, in which:
FIG. 1 is a schematic diagram of the steps of the present invention.
FIG. 2 is a schematic diagram of the sites of the present invention.
FIG. 3 is a schematic diagram of the sites of the present invention.
Detailed Description
For a better understanding of the technical content of the present invention, specific examples are set forth below, along with the accompanying drawings. Aspects of the invention are described in this disclosure with reference to the drawings, in which are shown a number of illustrative embodiments. The embodiments of the present disclosure need not be defined to include all aspects of the present invention. It should be understood that the various concepts and embodiments described above, as well as those described in more detail below, may be implemented in any of a number of ways, as the disclosed concepts and embodiments are not limited to any implementation. Additionally, some aspects of the disclosure may be used alone or in any suitable combination with other aspects of the disclosure.
The face is one of the most densely distributed regions of nerve endings in the human body, and is also the most expressive part, and is an important organ for people's emotion, thinking and external communication. Along with the continuous improvement of the living standard of people, the demands for facial rejuvenation are increased, various facial rejuvenation technologies and projects are increased, the skin is tender or deep wrinkle is removed, pain stimulation of the skin is involved, various facial rejuvenation projects can be completed comfortably, painlessly and loosely, and the important points and difficulties are faced when the projects are developed.
The traditional common skin painless measures comprise externally applying auxiliary materials (such as lidocaine patch, ointment and the like) containing anesthetic on the face,
it needs to be applied for more than 30 minutes, and the application time is long. The fine part of the anatomy (the part around the eye, nose bridge, nose root, nose tip, etc.) cannot be covered or is not covered completely, and the pain relieving effect is poor. Nerve blocking on the trigeminal nerve and the facial nerve branches can effectively form a facial painless area, is convenient for the implementation of facial rejuvenation technology, has extremely high requirements on operators, and can be implemented by a professional technical training party: (1) when the nerve is blocked, the puncture part has deviation, so that the blocking effect is poor, and the subsequent operation is influenced; (2) incorrect manipulation is easy to accidentally injure nerves and accompanying blood vessels, and causes complications such as nerve vascular injury, intracranial infection, facial paralysis, eyeball injury and the like.
The first point of facial rejuvenation operation is safety, and the second is natural and durable effect. The human face is one of the most complex regions of the human body, and new insights of different facial structures and complex correlations between them are continuously proposed in the research of facial shaping. The open or non-open treatment of cosmetic surgery is varied in order to slow down aging and restore youthful and beautiful facial appearance.
According to the above situation, we propose a facial painless technical solution based on neuromuscular blockade, simplifying the operation flow, facilitating clinical implementation.
Example 1:
as shown in fig. 2, as shown: point a, located at the orbital rim above the pupil; point B, located at the orbital rim below the pupil; the point C is positioned outside the angle of the mouth and above the lower edge of the mandible and can be positioned on the same straight line with the point A and the point B; a point D, which is positioned at the inner side end of the eyebrow; e, locating at the nose root and inner canthus part of eye; point F, located at the outer canthus, orbital rim of the eye; and the G point is positioned at the outer side end of the eyebrow and the position of the eyebrow tip.
Preparing medicine injection A and B, and preparing the injection A: 5ml of 2% lidocaine is added with 5ml of water for injection or 0.9% saline to prepare 1% lidocaine injection; preparation of injection B: dissolving and diluting the freeze-dried botulinum toxin A powder with 2ml of physiological saline, extracting 2ml of the dissolved and diluted solution, and mixing with 2ml of prepared injection A to prepare injection B for later use.
Marking the points A-G by a marker pen, sterilizing the face by using a sterilizing liquid (iodophor, chlorhexidine or 75% alcohol, etc.), extracting 2ml of the injection liquid A by using an injector, connecting a 22G needle head, inserting the needle at the positioning point, stopping inserting the needle after touching the bone face, withdrawing no blood, slowly injecting 0.5ml of the injection liquid to form a local skin dome, withdrawing the needle immediately, lightly kneading the injection part, fading Li Piqiu, diffusing the liquid medicine, blocking each nerve branch near the injection point, and completing painless operation.
Description: point A corresponds to the trigeminal branch, the supraorbital nerve, innervating the skin sensation in the forehead region; point B corresponds to the branch of the trigeminal nerve, the infraorbital nerve, innervating the skin sensations of the lateral nasal, cheek, upper lip and temporal; point C corresponds to the branches of the trigeminal nerve-the chin nerve, innervating the skin sensation of the labia, mandible and part of the temporal part; point D corresponds to the supratrochlear nerve, innervating the skin feel between the eyebrows; point E corresponds to the nasal ciliary nerves, corresponds to the skin feel of the nasal root, bridge of the nose, wings of the nose; F. point G, corresponding to the zygomatic temporal nerve, innervates the periocular lateral temporal skin sensation.
After the above operation is completed, the numbness, hypoesthesia and pain of the face can be quickly obtained, and the painless purpose can be achieved.
The method takes visible anatomical structures of the pupil, the eyebrow, the angle of the mouth, the inner canthus and the outer canthus of the eye and the like as positioning marks, can rapidly position, and has high safety because the deep layers of the positioning points are bone structures. Considering the deviation between the injection of the medicine and the running direction of the nerve, the medicine may deviate from nerve fibers, be injected near the nerve, and the diffusion range of the medicine liquid is enlarged through local kneading after injection, thereby improving the analgesic effect.
The method is matched with the injection of the botulinum toxin type A and the injection of the collagenase filler, so that remarkable face youthful promotion can be obtained, specifically, the injection B is taken, 1-2 ml of the injection B is injected into each part in a layered manner according to a promotion and shaping scheme, the face shaping is finished, and the operations of the collagenase injection, the face wrinkle removal, the photon skin tendering and the like which need painless can be performed on the basis of the painless treatment scheme.
Specifically, as shown in fig. 3, (1) upper face lifting shaping: the needle insertion point is positioned at the position of the eyebrow tip, the needle is inserted in a fan shape along the subcutaneous/deep fascia gap, the needle insertion depth is 2-3 cm, the anterior muscle bundle of the temporal muscle is reached, the injection B2 ml is injected for neuromuscular blocking hysteresis, the area where the external canthus is positioned, namely the area outside the upper face is lifted, and the sagging outside the upper face is corrected. (2) Middle face promotes moulding: the needle insertion point is positioned at the highest point of the zygomatic arch, is obliquely positioned at 30 degrees above the highest point, is in a fan shape along the subcutaneous/deep fascia space (SMAS), has the needle insertion depth of 4-5 cm, is respectively injected with injection B2 ml along the upper, middle and lower edges of the zygomatic arch in each direction, can effectively lift the external angle of the mouth by neuromuscular blocking and hysteresis, lightens the frenulum, and corrects the external sagging of the middle surface.
After the two steps, the lifting and shaping of the upper face and the middle face are completed.
The positioning points are shallow, and can reach the bone surface by penetrating 3-4 mm of the skin, so that the needle cannot be inserted too deeply in the operation process, so that the deep tissue structure is not damaged. After puncturing in place, attention is paid to back suction, and the injection of the medicine into the blood vessel is avoided.
According to the facial overall shaping method, the facial overall shaping can be carried out in a painless mode, the muscle block can shape the expression muscle of a specific part so as to achieve a facial shaping effect, the nerve block can prevent a patient from feeling pain, the whole process is painless, the problem that the shaping process is greatly plagued by pain of a user in the shaping process is solved, the experience of the user is good, smooth carrying out of the shaping process is facilitated, the shaping process becomes civilized, quiet and elegant, the operation time can be shortened, and the user obtains better comfort and satisfaction.
The invention carries out positioning marking by means of the body surface structures such as pupils, eyebrows, inner canthus and the like which are visible to naked eyes and are easy to identify, and the method is simple and convenient and is easy to operate. According to the neuroanatomical positioning, the neuroanatomical position is not emphasized any more, but the body surface marks are highlighted; is easier to learn and memorize. According to the lag of points A-G, the whole face can be painless. The oblique upward, backward and upward injection and shaping of the temporal muscle and the zygomatic arch part are the core of the invention, mainly act on the SMAS and are the cores of facial shaping and lifting.
While the invention has been described with reference to preferred embodiments, it is not intended to be limiting. Those skilled in the art will appreciate that various modifications and adaptations can be made without departing from the spirit and scope of the present invention. Accordingly, the scope of the invention is defined by the appended claims.
Claims (6)
1. A painless facial overall shaping method based on facial neuromuscular blockade, which is characterized in that: the method comprises the following steps:
s1: positioning point mark before injection: as shown in the figure, each positioning point A, B, C, D, E, F, G is marked by a marker, and the point A is positioned at the orbital margin above the pupil; point B, located at the orbital rim below the pupil; the point C is positioned outside the angle of the mouth and above the lower edge of the mandible and can be positioned on the same straight line with the point A and the point B; a point D, which is positioned at the inner side end of the eyebrow; e, locating at the nose root and inner canthus part of eye; point F, located at the outer canthus, orbital rim of the eye; the G point is positioned at the outer side end of the eyebrow and the position of the eyebrow tip;
wherein, point a corresponds to the trigeminal branch, the supraorbital nerve, innervating skin sensation in the forehead region; point B corresponds to the branch of the trigeminal nerve, the infraorbital nerve, innervating the skin sensations of the lateral nasal, cheek, upper lip and temporal; point C corresponds to the branches of the trigeminal nerve-the chin nerve, innervating the skin sensation of the labia, mandible and part of the temporal part; point D corresponds to the supratrochlear nerve, innervating the skin feel between the eyebrows; point E corresponds to the nasal ciliary nerves, corresponds to the skin feel of the nasal root, bridge of the nose, wings of the nose; F. point G, corresponding to the zygomatic temporal nerve, innervates the periocular lateral temporal skin sensation;
s2: the preparation method of the injection A and the injection B comprises the following steps: preparation of injection A: 5ml of 2% lidocaine is added with 5ml of water for injection or 0.9% saline to prepare 1% lidocaine injection; preparation of injection B: dissolving and diluting 2ml of physiological saline to obtain freeze-dried powder of botulinum toxin A, extracting 2ml of the dissolved and diluted solution, and mixing with 2ml of prepared injection A to prepare injection B for later use;
s3: sterilizing the face by using a sterilizing liquid, extracting 2ml of the injection A by using an injector, connecting a 22G needle head, inserting the needle at the positioning point, stopping inserting the needle after touching the bone surface, withdrawing no blood, slowly injecting 0.5ml of the injection to form a local skin dome, withdrawing the needle immediately, lightly kneading an injection part, performing compression hemostasis, and simultaneously performing Li Piqiu regression and liquid medicine diffusion to block nerve branches near the injection point to finish painless operation;
s4: taking injection B, injecting injection B1-2 ml in layers according to a lifting and shaping scheme, and finishing facial shaping, wherein the upper facial lifting shaping comprises upper facial lifting shaping and middle facial lifting shaping, wherein a needle inlet point is positioned at the position of an eyebrow tip obliquely outwards and upwards, a needle is in a fan shape along a subcutaneous/deep fascia gap, the needle inlet depth is 2-3 cm, the injection B2 ml reaches the anterior muscle bundle of temporal muscles, neuromuscular blocking lag is carried out, and the area where the external canthus is positioned, namely the lifting of the outer part of the upper face and the sagging of the outer side of the upper face can be effectively lifted;
the middle facial lifting and shaping is as follows, the needle insertion point is located at the highest point of the zygomatic arch, is obliquely located at 30 degrees above the outer side, is in a fan shape along the subcutaneous/deep fascia space (SMAS), the needle insertion depth is 4-5 cm, and injection liquid B2 ml is respectively injected along the upper, middle and lower edges of the zygomatic arch in each direction, so that the external angle of the mouth can be effectively lifted, the stature lines are lightened, and the sagging of the outer side of the middle facial is corrected.
2. A painless facial total body shaping method based on facial neuromuscular blockade as claimed in claim 1, wherein: point a, located at the orbital rim above the pupil; point B, located at the orbital rim below the pupil; the point C is positioned outside the angle of the mouth and above the lower edge of the mandible and can be positioned on the same straight line with the point A and the point B; a point D, which is positioned at the inner side end of the eyebrow; e, locating at the nose root and inner canthus part of eye; point F, located at the outer canthus, orbital rim of the eye; and the G point is positioned at the outer side end of the eyebrow and the position of the eyebrow tip.
3. A painless facial total body shaping method based on facial neuromuscular blockade as claimed in claim 1, wherein: A. b, C, D, E, F, G the locating points are shallow, penetrate 3-4 mm of skin and can reach the bone surface, and the needle cannot be inserted too deeply in the operation process so as to avoid hurting deep tissue structures, and after puncturing in place, the medicine is carefully sucked back to avoid being injected into blood vessels.
4. A painless facial total body shaping method based on facial neuromuscular blockade as claimed in claim 1, wherein: the disinfectant in the step S3 is iodophor, chlorhexidine or 75% alcohol.
5. A painless facial total body shaping method based on facial neuromuscular blockade as claimed in claim 1, wherein: and S3, determining needle insertion depth and needle insertion angle according to facial conditions, performing layer-by-layer infiltration anesthesia, wherein the needle insertion is based on human tissue anatomical structures, and the anesthesia needle enters each human tissue anatomical structure layer through the epidermis to perform layer-by-layer infiltration anesthesia.
6. A painless facial total body shaping method based on facial neuromuscular blockade as claimed in claim 1, wherein: cleaning skin before injection, inspecting skin, carefully inspecting the part of the patient to be injected by using an illumination device, determining whether the part of the patient to be injected has skin diseases, active bacterial or viral infections, inflammatory diseases and the like, stopping injection if the skin diseases exist, continuing the subsequent injection process if the skin diseases exist, and carefully disinfecting the line drawing part by using iodophor before injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211014391.3A CN117281993A (en) | 2022-08-23 | 2022-08-23 | Painless facial integral shaping method based on facial neuromuscular block |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211014391.3A CN117281993A (en) | 2022-08-23 | 2022-08-23 | Painless facial integral shaping method based on facial neuromuscular block |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117281993A true CN117281993A (en) | 2023-12-26 |
Family
ID=89237803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211014391.3A Pending CN117281993A (en) | 2022-08-23 | 2022-08-23 | Painless facial integral shaping method based on facial neuromuscular block |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117281993A (en) |
-
2022
- 2022-08-23 CN CN202211014391.3A patent/CN117281993A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4987149B1 (en) | acupuncture | |
| Miller | Cosmetic surgery: the correction of featural imperfections | |
| CN108478418B (en) | Non-invasive physiotherapy tool with acupuncture needle | |
| RU2135122C1 (en) | Method for producing skin rejuvenascence | |
| KR102120245B1 (en) | Method for operating eyebrow growth | |
| CN117281993A (en) | Painless facial integral shaping method based on facial neuromuscular block | |
| CN201076550Y (en) | Eye therapy health care implement | |
| CN111743584A (en) | Preoperative shaping method for face catgut embedding | |
| CN208851978U (en) | Shi justifies the noninvasive surgical instruments of nine kinds of needles | |
| WO2007114732A1 (en) | Wrinkle removing method | |
| Bertossi et al. | Puzzle Facelift: A Nonsurgical, Whole Treatment for Facial Modeling and Rejuvenation | |
| RU2186529C2 (en) | Method for correcting age alterations of facial and neck skin | |
| CN213642117U (en) | Acupuncture needle for face | |
| CN220327726U (en) | Kit for detecting a substance in a sample | |
| KR20140071885A (en) | Gold thread injection device for skin rejuvenation | |
| RU2816479C1 (en) | Method for natural recovery of face and neck skin tone | |
| CN108523947A (en) | A kind of fat formula face shaping method | |
| JP5128715B1 (en) | acupuncture | |
| Cui et al. | Minimally Invasive Approach to Facial Rejuvenation | |
| CN117179832A (en) | Protein line lifting method for facial cosmetology | |
| Beer et al. | Cosmetic uses of botulinum toxin A | |
| CN111920387A (en) | Pressing injection method for facial anti-aging | |
| Nazem et al. | Depth of Treatment in the Facial Rejuvenation: The Neglected Point in Facial Mesotherapy | |
| Hong et al. | Basic Technique for Filler Procedure | |
| CN117243810A (en) | Facial beautifying method based on acupoint stimulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |